|
1
|
Amberger JS, Bocchini CA, Scott AF and
Hamosh A: OMIM.org: Leveraging knowledge across phenotype-gene
relationships. Nucleic Res. 47:D1038–D1043. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Balakrishnan RK, Chandran SR,
Thirumalnesan G and Doraisamy N: Thyrotoxic periodic paralysis.
Indian J Endocrinol Metabolism. 15 (Suppl 2):S147–S149.
2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Schalin-Jantti C, Laine T, Valli-Jaakola
K, Lonnqvist T, Kontula K and Valimaki MJ: Manifestation,
management and molecular analysis of candidate genes in two rare
cases of thyrotoxic hypokalemic periodic paralysis. Horm Res.
63:139–144. 2005.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kung AW: Clinical review: Thyrotoxic
periodic paralysis: A diagnostic challenge. J Clin Endocrinol
Metab. 91:2490–2495. 2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tran HA: Inadvertent iodine excess causing
thyrotoxic hypokalemic periodic paralysis. Arch Intern Med.
165:2536. 2005.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Dias Da Silva MR, Cerutti JM, Arnaldi LA
and Maciel RM: A mutation in the KCNE3 potassium channel gene is
associated with susceptibility to thyrotoxic hypokalemic periodic
paralysis. J Clin Endocrinol Metab. 87:4881–4884. 2002.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kim TY, Song JY, Kim WB and Shong YK:
Arg16Gly polymorphism in beta2-adrenergic receptor gene is not
associated with thyrotoxic periodic paralysis in Korean male
patients with Graves' disease. Clin Endocrinol (Oxf). 62:585–589.
2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kung AW, Lau KS, Cheung WM and Chan V:
Thyrotoxic periodic paralysis and polymorphisms of sodium-potassium
ATPase genes. Clin Endocrinol (Oxf). 64:158–161. 2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang W, Jiang L, Ye L, Zhu N, Su T, Guan
L, Li X and Ning G: Mutation screening in Chinese hypokalemic
periodic paralysis patients. Mol Genet Metab. 87:359–363.
2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ryan DP, da Silva MR, Soong TW, Fontaine
B, Donaldson MR, Kung AW, Jongjaroenprasert W, Liang MC, Khoo DH,
Cheah JS, et al: Mutations in potassium channel Kir2.6 cause
susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell.
140:88–98. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Villarreal-Martinez A, Gallardo-Blanco H,
Cerda-Flores R, Torres-Muñoz I, Gómez-Flores M, Salas-Alanís J,
Ocampo-Candiani J and Martínez-Garza L: Candidate gene
polymorphisms and risk of psoriasis: A pilot study. Exp Ther Med.
11:1217–1222. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gallardo-Blanco HL, Villarreal-Perez JZ,
Cerda-Flores RM, Figueroa A, Sanchez-Dominguez CN,
Gutierrez-Valverde JM, Torres-Muñoz IC, Lavalle-Gonzalez FJ,
Gallegos-Cabriales EC and Martinez-Garza LE: Genetic variants in
KCNJ11, TCF7L2 and HNF4A are associated with type 2 diabetes, BMI
and dyslipidemia in families of Northeastern Mexico: A pilot study.
Exp Ther Med. 13:523–529. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Carpenter D, Ringrose C, Leo V, Morris A,
Robinson RL, Halsall PJ, Hopkins PM and Shaw MA: The role of
CACNA1S in predisposition to malignant hyperthermia. BMC Med Genet.
10(104)2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kung AW, Lau KS, Fong GC and Chan V:
Association of novel single nucleotide polymorphisms in the calcium
channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic
paralysis. J Clin Endocrinol Metab. 89:1340–1345. 2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the American college
of medical genetics and genomics and the association for molecular
pathology. Genet Med. 17:405–424. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kosoy R, Nassir R, Tian C, White PA,
Butler LM, Silva G, Kittles R, Alarcon-Riquelme ME, Gregersen PK,
Belmont JW, et al: Ancestry informative marker sets for determining
continental origin and admixture proportions in common populations
in America. Hum Mutat. 30:69–78. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kwon H, Jung JH, Han KD, Park YG, Cho JH,
Lee DY, Han JM, Park SE, Rhee EJ and Lee WY: Prevalence and annual
incidence of thyroid disease in Korea from 2006 to 2015: A
nationwide population-based cohort study. Endocrinol Metab (Seoul).
33:260–267. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lu KC, Hsu YJ, Chiu JS, Hsu YD and Lin SH:
Effects of potassium supplementation on the recovery of thyrotoxic
periodic paralysis. Am J Emerg Med. 22:544–547. 2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Dias da Silva MR, Cerutti JM, Tengan CH,
Furuzawa GK, Vieira TC, Gabbai AA and Maciel RM: Mutations linked
to familial hypokalaemic periodic paralysis in the calcium channel
alpha1 subunit gene (Cav1.1) are not associated with thyrotoxic
hypokalaemic periodic paralysis. Clin Endocrinol(Oxf). 56:367–375.
2002.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Nie M, Bal MS, Yang Z, Liu J, Rivera C,
Wenzel A, Beck BB, Sakhaee K, Marciano DK and Wolf MT: Mucin-1
increases renal trpv5 activity in vitro, and urinary level
associates with calcium nephrolithiasis in patients. J Am Soc
Nephrol. 27:3447–3458. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Meyer TE, Verwoert GC, Hwang SJ, Glazer
NL, Smith AV, van Rooij FJ, Ehret GB, Boerwinkle E, Felix JF, Yang
Q, et al: Genome-wide association studies of serum magnesium,
potassium, and sodium concentrations identify six Loci influencing
serum magnesium levels. PLoS Genet. 6(e1001045)2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tin A, Kottgen A, Folsom AR, Maruthur NM,
Tajuddin SM, Nalls MA, Evans MK, Zonderman AB, Friedrich CA,
Boerwinkle E, et al: Genetic loci for serum magnesium among
African-Americans and gene-environment interaction at MUC1 and
TRPM6 in European-Americans: The Atherosclerosis Risk in
Communities (ARIC) study. BMC Genet. 16(56)2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Blaine J, Chonchol M and Levi M: Renal
control of calcium, phosphate, and magnesium homeostasis. Clin J Am
Soc Nephrol. 10:1257–1272. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kardalas E, Paschou SA, Anagnostis P,
Muscogiuri G, Siasos G and Vryonidou A: Hypokalemia: A clinical
update. Endocr Connect. 7:R135–R146. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
1000 Genomes Project Consortium. Auton A,
Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL,
McCarthy S, McVean GA and Abecasis GR: A global reference for human
genetic variation. Nature. 526:68–74. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang W, Wang A, Luo G, Ma F, Wei X and Bi
Y: S1P1 receptor inhibits kidney epithelial mesenchymal transition
triggered by ischemia/reperfusion injury via the PI3K/Akt pathway.
Acta Biochim Biophys Sin (Shanghai). 50:651–657. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Silva MR, Chiamolera MI, Kasamatsu TS,
Cerutti JM and Maciel RM: Thyrotoxic hypokalemic periodic
paralysis, an endocrine emergency: Clinical and genetic features in
25 patients. Arq Bras Endocrinol Metabol. 48:196–215. 2004.(In
Portuguese). PubMed/NCBI View Article : Google Scholar
|
|
28
|
Garber M, Guttman M, Clamp M, Zody MC,
Friedman N and Xie X: Identifying novel constrained elements by
exploiting biased substitution patterns. Bioinformatics.
25:i54–i62. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Moreno-Estrada A, Gignoux CR,
Fernández-López JC, Zakharia F, Sikora M, Contreras AV,
Acuña-Alonzo V, Sandoval K, Eng C, Romero-Hidalgo S, et al: Human
genetics. The genetics of Mexico recapitulates Native American
substructure and affects biomedical traits. Science. 344:1280–1285.
2014.PubMed/NCBI View Article : Google Scholar
|
